Dolan Oliver: insider trades.
Dolan Oliver reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($99K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Dolan Oliver
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Korro Bio, Inc. (KRRO) | Officer · Senior Vice President, Finance | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Korro Bio, Inc. | S | 5 | $13.72 | 16,241 | Form 4 |
| 2026-09-09 | Korro Bio, Inc. | S | 6 | $13.6 | 16,246 | Form 4 |
| 2026-09-08 | Korro Bio, Inc. | S | 7,347 | $13.51 | 16,252 | Form 4 |
| 2026-07-15 | Korro Bio, Inc. | A | 5,500 | $0 | 23,599 | Form 4 |
Questions
What stock did Dolan Oliver buy or sell?
Dolan Oliver reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($99K), across 1 company.
Is Dolan Oliver the same person as other filers with this name?
This page covers SEC CIK 2053835 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/dolan-oliver-2053835.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.